Paper7002425
Effects of pindolol on renal function.
Wainer E and 2 others. Clin Pharmacol Ther, 1980. Cited by 23 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of pindolol on renal function. Papers, record 7002425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7002425
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney | Major topic |
| Pindolol | Major topic |
| Adult | |
| Aged | |
| Blood Pressure | |
| Cardiac Output | |
| Glomerular Filtration Rate | |
| Humans | |
| Inulin | |
| Middle Aged | |
| Renin |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,595,506 | Conventional Pig as Animal Model for Human Renal Drug Excretion Processes: Unravelling the Porcine Renal Function by Use of a Cocktail of Exogenous Markers. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32595506 | PubMed |
| 25,432,141 | Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds. | Crit Care | 2014 | https://conductscience.org/library/papers/25432141 | PubMed |
| 11,422,014 | Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol. | Br J Clin Pharmacol | 2001 | https://conductscience.org/library/papers/11422014 | PubMed |
| 7,104,147 | Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104147 | PubMed |
| 6,125,169 | Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6125169 | PubMed |
| 6,122,552 | Beta-blockers and renal function. | Drugs | 1982 | https://conductscience.org/library/papers/6122552 | PubMed |
| 2,905,992 | Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/2905992 | PubMed |
| 2,567,670 | Responses of glomerular filtration, renal blood flow and salt-water handling to acute cardioselective and non-selective beta-adrenoceptor blockade in essential hypertension. | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2567670 | PubMed |
| 2,187,701 | Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension. | Eur J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2187701 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5,972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7002425
GET https://conductscience.org/api/papers/v1/7002425/authors